News

Find News

Filter articles

Showing 2401 to 2410 of 2541 results

Supreme Court hears Medtronic case

US11-11-2013Legal developments

On November 5, the US Supreme Court heard oral arguments in the Medtronic Inc v Boston Scientific Corporation case to determine whether the patent holder or licensee bears the burden of proof in matters where declaratory judgment of non-infringement has been sought.

Syntrix celebrates US damages ruling

US08-11-2013

A federal court has upheld a ruling that biotech company Illumina should pay rival Syntrix $115 million and an 8 percent running royalty rate for patent infringement.

Forest and Actavis settle over blood pressure drug

US08-11-2013

US pharmaceutical company Forest Laboratories and drug company Actavis have settled a legal dispute over a patent protecting blood pressure drug Bystoli (nebivolol).

SPC questions referred to CJEU in Actavis v Boehringer

EU, UK07-11-2013

The UK Patents Court has referred four questions to the CJEU seeking clarification on how the SPC Regulation should be interpreted in relation to drug products made of a combination of active ingredients.

Myriad decision applied in diagnostic claims case

US06-11-2013Legal developments

The US District Court for the Northern District of California has found that diagnostic claims covering conventional detection methods do not make the use of a natural phenomenon patent eligible.

Botox prevails with Botulex challenge

US06-11-2013

A US trademark for Botulex would be too confusingly similar to Botox if granted, the Trademark Trial and Appeal Board has ruled.

Pfizer wins IL-13 priority over Sanofi

US06-11-2013

The US Court of Appeals for the Federal Circuit affirmed on Tuesday that pharmaceutical company Pfizer can patent a DNA polynucleotide ahead of rival Sanofi-Aventis.

Novartis petitions FDA on biosimilar naming convention

US01-11-2013

Novartis has urged the FDA to allow biosimilars to bear the same international nonproprietary names as their reference products.

Indian Patent Office rejects bid for cancer drug compulsory licence

India31-10-2013

The Indian Patent Office has rejected an application for a compulsory licence that was filed by domestic drug maker BDR Pharmaceuticals.

No plant SPCs after emergency orders – CJEU

EU, Germany31-10-2013

Europe’s highest court has said supplementary protection certificates for plant protection products cannot be granted after the same product has been authorised on emergency grounds.

Showing 2401 to 2410 of 2541 results

LSIPR